School of Medicine

Showing 1-10 of 37 Results

  • Rodney U. Anderson, MD FACS

    Rodney U. Anderson, MD FACS

    Professor (Clinical) of Urology, Emeritus

    Current Research and Scholarly Interests Clinical Medical Research devoted to tertiary level application of treatment modalities for neurologic and functional disturbances of the genitourinary tract. Problems such as urinary incontinence, urinary retention, urinary flow dysfunction (BPH), impotence, and chronic pelvic pain syndromes are addressed. New medical devices and technology for treating these disorders are investigated

  • James D. Brooks

    James D. Brooks

    Keith and Jan Hurlbut Professor in the Stanford University School of Medicine

    Current Research and Scholarly Interests We use genomic approaches to identify disease biomarkers. We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer.

  • Bertha Chen

    Bertha Chen

    Professor of Obstetrics and Gynecology (General Gynecology) and, by courtesy, of Urology at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Chen’s research examines the molecular causes of urinary incontinence and pelvic floor dysfunction. Recognizing that urinary incontinence linked to demise of smooth muscle sphincter function, she is investigating the potential use of stem cell regeneration to restore muscle capacity.

  • Benjamin I. Chung

    Benjamin I. Chung

    Assistant Professor of Urology at the Stanford University Medical Center

    Current Research and Scholarly Interests Renal cell carcinoma and prostate cancer outcomes research and epidemiology.

  • Craig V. Comiter

    Craig V. Comiter

    Professor of Urology and, by courtesy, of Obstetrics and Gynecology at the Stanford University Medical Center

    Current Research and Scholarly Interests Using various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.

    I also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.

    I am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC.

  • Christos E. Constantinou

    Christos E. Constantinou

    Associate Professor of Urology, Emeritus

    Current Research and Scholarly Interests My main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.

  • Harcharan Gill

    Harcharan Gill

    Associate Professor of Urology at the Stanford University Medical Center

    Current Research and Scholarly Interests Benign Prostatic Hyperplasia- Evaluation and development of new minimally invasive techniques

    Endourology: developing, designing and evaluating new instruments

    Bladder cancer: outcomes of treatment

    BPH: cryotherapy and HIFU

  • Catherine A. Gordon

    Catherine A. Gordon

    Postdoctoral Research fellow, Urology

    Current Research and Scholarly Interests Prostate cancer is a major health problem in the United States. The American Cancer Society estimates that one out of six men will be diagnosed with prostate cancer during his lifetime, while one out of thirty-six men will die from it. Since most men will not acquire an aggressive and potentially lethal form of the disease, the challenge is being able to distinguish between aggressive and indolent forms of prostate cancer, and properly treating the aggressive forms.

    We have recently identified nucleolar and spindle-associated protein (NUSAP1; encoding NuSAP) as a prognosticator for prostate cancer. We found that NUSAP1 is over-expressed in recurrent prostate cancer tumors, and validated this correlation in independent prostate cancer datasets. Although NuSAP is known to be essential for cell cycle progression, faithfully binding to and stabilizing microtubules during mitosis, little is known about its role in prostate cancer progression. Hence, we are performing an extensive analysis to understand the role of NuSAP in aggressive prostate cancer. In particular, we are investigating the regulation and role of NuSAP in mechanisms of proliferation, invasion, apoptosis, cellular movement, cell cycle progression, metastasis, tumor growth, and responses to chemotherapy. Understanding the role of NuSAP in prostate cancer progression will provide insights into the inner workings of aggressive cancer cells, and may lead to new ways to prognosticate and treat aggressive forms of prostate cancer.

Stanford Medicine Resources: